ArticlePloS one2022

Costs, effectiveness, and safety associated with Chimeric Antigen Receptor (CAR) T-cell therapy: Results from a comprehensive cancer center.

Sérgio Chacim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.